Company Search:
Advanced Search
Sponsored Links
Exelixis, Inc. Company Snapshot
Exelixis, Inc. operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Exelixis with three other companies in this sector in the United States: Exact Sciences Corporation (2015 sales of $39.44 million of which 100% was License fees), AC Immune Ltd ($40.54 million of which 100% was Pharmaceutical), and Luna Innovations Incorporated ($44.02 million ).

Sales Analysis. Exelixis reported sales of $37.17 million for the year ending December of 2015. This represents an increase of 48.0% versus 2014, when the company's sales were $25.11 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Exelixis, Inc.
  Stock Performance Chart for Exelixis, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): 17.92
(Figures in U.S. Dollars)
1 Week -3.2%   13 Weeks 16.3%  
4 Weeks 55.0%   52 Weeks 290.4%  
Exelixis, Inc. Key Data:
  Ticker: EXEL Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 37,172,000
(Year Ending Jan 2016).
Employees: 115
  Currency: U.S. Dollars Market Cap: 5,133,290,033
  Fiscal Yr Ends: December Shares Outstanding: 286,455,917
  Share Type: Common Closely Held Shares: 25,759,242
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.